Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Citigroup Issues Callable Contingent Coupon Notes Linked to Three Major Stock Market Indices

Citigroup Global Markets Holdings Inc. has filed a preliminary pricing supplement for a new structured debt offering of Medium-Term Senior Notes due July 26, 2029. The securities, guaranteed by Citigroup Inc., offer contingent coupon payments based on the performance of the worst-performing of three …

Aakashdeep | 15 July 2026

JPMorgan Chase Launches Uncapped Buffered S&P 500 Futures Notes With 2.00x Upside Leverage and 20% Protection

JPMorgan Chase Financial Company LLC priced $465,000 in structured notes on July 14, 2026, offering investors uncapped upside returns of 2.00 times any S&P 500 Futures Excess Return Index appreciation, subject to an 80% maximum loss threshold. The notes, which settle on or about …

Aditi Sarkar | 15 July 2026

Bank of Nova Scotia Issues Buffered PLUS Securities Linked to S&P 500 Index With Leveraged Upside and Capital Protection Buffer

The Bank of Nova Scotia (BNS) disclosed a preliminary pricing supplement on July 16, 2026, for the issuance of Dual Directional Buffered PLUS securities due August 3, 2028. The structured notes, priced at $1,000 per security, offer investors a 150% leverage factor on upside …

Shwetambri Chauhan | 15 July 2026

Bank of Nova Scotia Launches $12.5 Million Trigger Autocallable GEARS Linked to Nikkei 225 Index

The Bank of Nova Scotia disclosed a new structured debt offering on July 16, 2026, consisting of $12.5 million in Trigger Autocallable GEARS securities linked to the performance of the Nikkei 225 Index. The securities, which mature on July 17, 2031, feature an automatic …

Nitish Kishor | 15 July 2026

BofA Finance Launches Abbott Laboratories-Linked Auto-Callable Notes with 10.46% Contingent Coupon

BofA Finance LLC has filed a preliminary pricing supplement for Contingent Income Auto-Callable Yield Notes linked to Abbott Laboratories common shares, scheduled to price on July 30, 2026 and issue on August 4, 2026. The notes, fully guaranteed by Bank of America Corporation, offer …

Nitish Kishor | 15 July 2026

Morgan Stanley Finance Issues Principal-at-Risk Structured Notes Linked to Stock Index Performance

Morgan Stanley Finance LLC announced the issuance of fixed-income securities with daily trigger monitoring tied to the performance of the S&P 500 and Russell 2000 indices, according to a pricing supplement dated July 16, 2026. The securities, which offer a 10.10% annual coupon but …

Vinay Lochav | 15 July 2026

JPMorgan Chase Financial Launches $785 Million Uncapped Buffered Digital Notes Linked to European Equity Indices

JPMorgan Chase Financial Company LLC priced $785 million in Uncapped Buffered Digital Notes on July 14, 2026, designed to provide investors with exposure to the EURO STOXX 50 Index and the iShares MSCI EAFE ETF. The structured investment product offers a fixed contingent return …

Aditi Sarkar | 15 July 2026

Bank of Nova Scotia Issues Five-Year Autocallable Notes Linked to Autodesk, Air Products, and Uber Stock Performance

The Bank of Nova Scotia has filed a preliminary pricing supplement for a new class of structured notes offering leveraged upside exposure to the combined performance of three major technology and industrial stocks. The Autocallable Contingent Buffered Return Enhanced Notes, due July 29, 2031, …

Vinay Lochav | 15 July 2026

Nuvalent Acquired by GSK for $124.00 Per Share as Tender Offer Closes and Merger Completes on July 15, 2026

Nuvalent, Inc., the Cambridge, Massachusetts-based biopharmaceutical company traded on the Nasdaq Global Select Market under the ticker NUVL, has been fully acquired by GlaxoSmithKline LLC, a subsidiary of GSK plc, following the successful completion of a cash tender offer and subsequent merger on July …

Manish Choudhary | 15 July 2026

Veradermics Reports Positive Phase 2 Topline Data for VDPHL01 in Female Pattern Hair Loss, Showing Average Hair Count Gains Above 22 Hairs per cm²

Veradermics, Incorporated, a Delaware-incorporated specialty dermatology company listed on the New York Stock Exchange under the ticker MANE, announced on July 15, 2026, that its Phase 2 clinical trial known as Study '207' produced positive topline results for VDPHL01, its proprietary extended-release oral minoxidil …

Manish Choudhary | 15 July 2026
Support

Hi! How can we help you today?

Loading…